nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Abnormalities of the hair—Hydrochlorothiazide—nephrolithiasis	0.12	0.12	CcSEcCtD
Isotretinoin—Erythema facial—Hydrochlorothiazide—nephrolithiasis	0.0548	0.0548	CcSEcCtD
Isotretinoin—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.0441	0.0441	CcSEcCtD
Isotretinoin—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0323	0.0323	CcSEcCtD
Isotretinoin—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.019	0.019	CcSEcCtD
Isotretinoin—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Isotretinoin—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Isotretinoin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0156	CcSEcCtD
Isotretinoin—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0145	CcSEcCtD
Isotretinoin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Isotretinoin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Isotretinoin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0124	CcSEcCtD
Isotretinoin—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0121	CcSEcCtD
Isotretinoin—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Isotretinoin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Isotretinoin—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Isotretinoin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0108	CcSEcCtD
Isotretinoin—Gout—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Isotretinoin—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Isotretinoin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Isotretinoin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Isotretinoin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Isotretinoin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Isotretinoin—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00972	0.00972	CcSEcCtD
Isotretinoin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Isotretinoin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00891	CcSEcCtD
Isotretinoin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00835	CcSEcCtD
Isotretinoin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00827	0.00827	CcSEcCtD
Isotretinoin—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00824	0.00824	CcSEcCtD
Isotretinoin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00798	0.00798	CcSEcCtD
Isotretinoin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0077	CcSEcCtD
Isotretinoin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00767	0.00767	CcSEcCtD
Isotretinoin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Isotretinoin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00748	0.00748	CcSEcCtD
Isotretinoin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00727	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00727	CcSEcCtD
Isotretinoin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00715	CcSEcCtD
Isotretinoin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00701	0.00701	CcSEcCtD
Isotretinoin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00688	0.00688	CcSEcCtD
Isotretinoin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00681	0.00681	CcSEcCtD
Isotretinoin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00666	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00654	CcSEcCtD
Isotretinoin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00643	CcSEcCtD
Isotretinoin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00632	CcSEcCtD
Isotretinoin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Isotretinoin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00616	CcSEcCtD
Isotretinoin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00587	CcSEcCtD
Isotretinoin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00587	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00584	CcSEcCtD
Isotretinoin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0058	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00573	CcSEcCtD
Isotretinoin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00572	CcSEcCtD
Isotretinoin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00563	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00555	0.00555	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00552	CcSEcCtD
Isotretinoin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0055	0.0055	CcSEcCtD
Isotretinoin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00549	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00549	CcSEcCtD
Isotretinoin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00544	CcSEcCtD
Isotretinoin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00544	CcSEcCtD
Isotretinoin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00537	CcSEcCtD
Isotretinoin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00534	CcSEcCtD
Isotretinoin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00528	CcSEcCtD
Isotretinoin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00525	CcSEcCtD
Isotretinoin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00523	CcSEcCtD
Isotretinoin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00503	CcSEcCtD
Isotretinoin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.005	0.005	CcSEcCtD
Isotretinoin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00499	0.00499	CcSEcCtD
Isotretinoin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00495	CcSEcCtD
Isotretinoin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00484	CcSEcCtD
Isotretinoin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00475	CcSEcCtD
Isotretinoin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00469	CcSEcCtD
Isotretinoin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00466	CcSEcCtD
Isotretinoin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00449	CcSEcCtD
Isotretinoin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00444	CcSEcCtD
Isotretinoin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00438	CcSEcCtD
Isotretinoin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00431	CcSEcCtD
Isotretinoin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00429	CcSEcCtD
Isotretinoin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00425	CcSEcCtD
Isotretinoin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00423	CcSEcCtD
Isotretinoin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00412	CcSEcCtD
Isotretinoin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0041	CcSEcCtD
Isotretinoin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00406	CcSEcCtD
Isotretinoin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00404	CcSEcCtD
Isotretinoin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00402	CcSEcCtD
Isotretinoin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00395	CcSEcCtD
Isotretinoin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00392	CcSEcCtD
Isotretinoin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00387	CcSEcCtD
Isotretinoin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00385	CcSEcCtD
Isotretinoin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00382	CcSEcCtD
Isotretinoin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00373	CcSEcCtD
Isotretinoin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00373	CcSEcCtD
Isotretinoin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00373	CcSEcCtD
Isotretinoin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00371	CcSEcCtD
Isotretinoin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00368	CcSEcCtD
Isotretinoin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00364	CcSEcCtD
Isotretinoin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0036	CcSEcCtD
Isotretinoin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00357	CcSEcCtD
Isotretinoin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00357	CcSEcCtD
Isotretinoin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00351	CcSEcCtD
Isotretinoin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0035	CcSEcCtD
Isotretinoin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00349	CcSEcCtD
Isotretinoin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00345	CcSEcCtD
Isotretinoin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.0034	CcSEcCtD
Isotretinoin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00334	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00325	CcSEcCtD
Isotretinoin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00323	CcSEcCtD
Isotretinoin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00321	CcSEcCtD
Isotretinoin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00318	CcSEcCtD
Isotretinoin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00317	CcSEcCtD
Isotretinoin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00314	CcSEcCtD
Isotretinoin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0031	0.0031	CcSEcCtD
Isotretinoin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00308	CcSEcCtD
Isotretinoin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00305	CcSEcCtD
Isotretinoin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00305	CcSEcCtD
Isotretinoin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00294	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00292	CcSEcCtD
Isotretinoin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00284	CcSEcCtD
Isotretinoin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00282	CcSEcCtD
Isotretinoin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00282	CcSEcCtD
Isotretinoin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00263	CcSEcCtD
Isotretinoin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00256	CcSEcCtD
Isotretinoin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00253	CcSEcCtD
Isotretinoin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00244	CcSEcCtD
Isotretinoin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00236	CcSEcCtD
Isotretinoin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00227	CcSEcCtD
Isotretinoin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00225	CcSEcCtD
Isotretinoin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00225	CcSEcCtD
Isotretinoin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00224	CcSEcCtD
Isotretinoin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00212	CcSEcCtD
